Osamu Ohara Selected Research

Osamu Ohara Research Topics

Disease

27	Neoplasms (Cancer) 11/2022 - 10/2003
14	Inflammation (Inflammations) 01/2022 - 10/2009
12	Infections 04/2023 - 12/2010
7	Virus Diseases (Viral Diseases) 01/2022 - 12/2011
7	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 08/2011
6	Leukemia 02/2016 - 05/2009
5	Primary Immunodeficiency Diseases 01/2019 - 01/2009
4	Cryopyrin-Associated Periodic Syndromes 01/2024 - 04/2012
4	Rheumatoid Arthritis 01/2023 - 05/2014
4	Asthma (Bronchial Asthma) 10/2020 - 05/2014
3	Fibrosis (Cirrhosis) 03/2024 - 01/2017
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 10/2021
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 04/2006
3	Pemphigus (Pemphigus Vulgaris) 10/2023 - 01/2020
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2023 - 12/2010
3	Bruton type agammaglobulinemia 10/2022 - 02/2015
3	Common Variable Immunodeficiency 10/2022 - 05/2013
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 08/2011
3	Chronic Granulomatous Disease 01/2021 - 05/2013
3	Job Syndrome (Hyper-IgE Syndrome) 01/2021 - 12/2014
3	Dermatitis 01/2021 - 01/2016
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2013
3	Chronic Mucocutaneous Candidiasis 12/2020 - 08/2012
3	Rhinosinusitis 10/2020 - 01/2019
3	Fever (Fevers) 01/2020 - 07/2014
3	Obesity 11/2018 - 07/2011
3	Adenocarcinoma 01/2018 - 12/2004
3	Carcinoma (Carcinomatosis) 01/2017 - 10/2003
3	Lung Neoplasms (Lung Cancer) 01/2017 - 11/2010
3	Wiskott-Aldrich Syndrome 11/2015 - 02/2013
3	Contact Dermatitis (Eczema, Contact) 05/2015 - 04/2003
2	COVID-19 10/2022 - 01/2022
2	Pneumonia (Pneumonitis) 10/2022 - 05/2014
2	2 X-Linked Lymphoproliferative Syndrome 01/2022 - 10/2021
2	Hepatitis 01/2022 - 12/2012
2	Thrombocytopenia (Thrombopenia) 08/2021 - 02/2013
2	Rare Diseases (Rare Disease) 07/2021 - 01/2008
2	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 04/2010
2	IRAK4 Deficiency 01/2021 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 12/2017
2	Fatty Liver 11/2020 - 07/2013
2	Colorectal Neoplasms (Colorectal Cancer) 06/2020 - 01/2018
2	Nasal Polyps (Nasal Polyp) 01/2020 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 01/2018
2	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 10/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2003
9	CytokinesIBA 09/2023 - 10/2009
8	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2016
8	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 04/2012
6	AntigensIBA 01/2020 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2014
5	ProteomeIBA 07/2023 - 11/2020
5	ChemokinesIBA 01/2018 - 04/2003
4	AutoantibodiesIBA 10/2023 - 04/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2014
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 11/2021 - 01/2004
4	InterferonsIBA 01/2020 - 11/2010
4	Immunoglobulins (Immunoglobulin)IBA 11/2018 - 05/2013
4	LigandsIBA 01/2018 - 12/2011
3	SteroidsIBA 01/2022 - 01/2004
3	Immunoglobulin M (IgM)IBA 01/2022 - 04/2013
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 05/2014
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2014
3	ZincIBA 01/2022 - 08/2014
3	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2013
3	STAT1 Transcription FactorIBA 12/2020 - 07/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 01/2019
2	InterleukinsIBA 01/2024 - 01/2022
2	Interleukin-1 (Interleukin 1)IBA 01/2024 - 01/2021
2	DesmogleinsIBA 10/2023 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 12/2021
2	Interferon Type IIBA 10/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 12/2021
2	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2022 - 10/2021
2	Desmoglein 3IBA 01/2022 - 01/2020
2	EnzymesIBA 12/2021 - 01/2019
2	Complement System Proteins (Complement)IBA 07/2021 - 10/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 07/2012
2	VaccinesIBA 01/2021 - 03/2016
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2006
2	PyrinIBA 01/2021 - 04/2010
2	AntibodiesIBA 01/2021 - 12/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2020
2	Peptides (Polypeptides)IBA 06/2020 - 02/2016
2	A-Form DNA (A-DNA)IBA 01/2020 - 12/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2014
2	CollagenIBA 01/2019 - 01/2017
2	InflammasomesIBA 01/2019 - 01/2015
2	CD40 Ligand (CD40L)IBA 10/2018 - 01/2018

Therapy/Procedure

15	Therapeutics 04/2023 - 11/2010
5	Immunotherapy 01/2017 - 01/2016
4	Hematopoietic Stem Cell Transplantation 01/2019 - 05/2009
3	Transplantation 11/2021 - 10/2005
2	Aftercare (After-Treatment) 10/2023 - 01/2019
2	Cell Transplantation 04/2023 - 10/2021
2	Stem Cell Transplantation 03/2019 - 03/2016